NRx Pharmaceuticals, Inc. NRXP
2.24 USD +0.07 (+3.23%)
At closeNov 3, 2026, 4:33 PM EST
2.27 +0.03 +1.34%
After hours · Nov 3, 4:33 PM ET
2.11 Day range 2.34
1.62 52-week range 5.06
- YTD
- -17.34%
- 1 year
- -21.40%
Analyst view
Price target (mean) 31.67 +1313.7% upside
Now 2.24
- Target (low)
- 19.00
- Target (mean)
- 31.67
- Target (high)
- 45.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.295 | -0.39 – -0.20 | -0.50 | +41.0% | 0 | 0.0% | 2 |
| Next quarter | -0.40 | -0.40 – -0.40 | -0.74 | +46.0% | 5.00M | 0.0% | 1 |
| Current year | -1.86 | -1.96 – -1.75 | -4.00 | +53.6% | 0 | 0.0% | 2 |
| Next year | -0.03 | -0.08 – 0.02 | -1.86 | +98.4% | 68.47M | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 2, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Nov 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 15, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Oct 30, 2024 | EF Hutton | Maintained | Buy | Buy |
| Oct 21, 2024 | EF Hutton | Initiated | — | Buy |
| Sep 12, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Aug 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 7, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| May 25, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 2, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Nov 9, 2022 | Ascendiant Capital | Initiated | — | Buy |
| Jun 30, 2022 | HC Wainwright & Co. | Initiated | — | Buy |